Pepsinogen II Can Be a Potential Surrogate Marker of Morphological Changes in Corpus before and after H. pylori Eradication.

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2014; pp. 481607 - 481608
Autores principales: Massarrat, Sadegh, Haj-Sheykholeslami, Arghavan, Mohamadkhani, Ashraf, Zendehdel, Nasrin, Aliasgari, Ali, Rakhshani, Naser, Stolte, Manfred, Shahidi, Seyed Mehdi
Formato: research randomized controlled trial Journal Article
Publicado: Wiley-Blackwell 2014
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103834169&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 103834169
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 2014
      vid: 2014
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        103834169
        103834169
        2012650464
        NLM25028655
        PMC4083213
        103834169
      ppf: 481607
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Pepsinogen II Can Be a Potential Surrogate Marker of Morphological Changes in Corpus before and after H. pylori Eradication.
      aug:
        au:
          Massarrat, Sadegh
          Haj-Sheykholeslami, Arghavan
          Mohamadkhani, Ashraf
          Zendehdel, Nasrin
          Aliasgari, Ali
          Rakhshani, Naser
          Stolte, Manfred
          Shahidi, Seyed Mehdi
        affil: Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran.
      sug:
        subj:
          Helicobacter Infections Blood
          Helicobacter Infections Therapy
          Helicobacter Pylori
          Enzymes Blood
          Stomach Neoplasms Blood
          Tumor Markers, Biological Blood
          Adult
          Aged
          Double-Blind Studies
          Female
          Human
          Male
          Middle Age
          Stomach Neoplasms Surgery
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      pubtype: Academic Journal
      doctype:
        research
        randomized controlled trial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N